ANO1 protein as a potential biomarker for esophageal cancer prognosis and precancerous lesion development prediction

OBJECTIVES: Anoctamin 1 (ANO1) has been found to be overexpressed in esophageal squamous cell carcinoma (ESCC) in our previous study. Herein we showed the clinical relevance of ANO1 alterations with ESCC and esophageal precancerous lesion progression. RESULTS: ANO1 was detected in 38.1% (109/286) an...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Oncotarget
Главные авторы: Shang, Li, Hao, Jia-Jie, Zhao, Xue-Ke, He, Jian-Zhong, Shi, Zhi-Zhou, Liu, Hui-Juan, Wu, Li-Fei, Jiang, Yan-Yi, Shi, Feng, Yang, Hai, Zhang, Yu, Liu, Yi-Zhen, Zhang, Tong-Tong, Xu, Xin, Cai, Yan, Jia, Xue-Mei, Li, Min, Zhan, Qi-Min, Li, En-Min, Wang, Li-Dong, Wei, Wen-Qiang, Wang, Ming-Rong
Формат: Artigo
Язык:Inglês
Опубликовано: Impact Journals LLC 2016
Предметы:
Research Paper
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5029708/
https://ncbi.nlm.nih.gov/pubmed/27016410
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.8223
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы